To the Editor.
作者信息
Raj Gerard Marshall, Mathaiyan Jayanthi
机构信息
Sri Venkateshwaraa Medical College and Jawaharlal Institute of Postgraduate Medical Education and Research in Puducherry, India.
出版信息
Ethn Dis. 2020 Sep 24;30(4):701-702. doi: 10.18865/ed.30.4.701. eCollection 2020 Fall.
Abstract
摘要
相似文献
1
To the Editor.致编辑。
Ethn Dis. 2020 Sep 24;30(4):701-702. doi: 10.18865/ed.30.4.701. eCollection 2020 Fall.
2
The Authors Reply.作者回复。
Ethn Dis. 2020 Sep 24;30(4):703-704. doi: 10.18865/ed.30.4.703. eCollection 2020 Fall.
3
Metformin transporter pharmacogenomics: insights into drug disposition-where are we now?二甲双胍转运体药物基因组学：药物处置的新视角——我们现在处于什么位置？
Expert Opin Drug Metab Toxicol. 2018 Nov;14(11):1149-1159. doi: 10.1080/17425255.2018.1541981. Epub 2018 Nov 13.
4
To the Editor: Metformin for type 2 diabetes.致编辑：二甲双胍用于2型糖尿病。
Cleve Clin J Med. 2019 Apr;86(4):237. doi: 10.3949/ccjm.86c.04003.
5
Pharmacogenetics of oral antidiabetic therapy.口服抗糖尿病治疗的药物遗传学
Pharmacogenomics. 2018 Apr;19(6):577-587. doi: 10.2217/pgs-2017-0195. Epub 2018 Mar 27.
6
Pharmacogenetics of metformin response: a step in the path toward personalized medicine.二甲双胍反应的药物遗传学：迈向个性化医疗道路上的一步。
J Clin Invest. 2007 May;117(5):1226-9. doi: 10.1172/JCI32133.
7
Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.致编辑的信，参考文章标题为：罗格列酮/二甲双胍固定剂量联合疗法与罗格列酮或二甲双胍单药疗法治疗2型糖尿病控制不佳患者的初始治疗比较
Diabetes Obes Metab. 2007 Nov;9(6):914. doi: 10.1111/j.1463-1326.2007.00721.x. Epub 2007 Mar 29.
8
Using EHR-Linked Biobank Data to Study Metformin Pharmacogenomics.利用与电子健康记录相关的生物样本库数据研究二甲双胍药物基因组学。
Stud Health Technol Inform. 2015;210:914-8.
9
[Oral hypoglycemic agents and metformin in the treatment of type II non-insulin-dependent diabetes].口服降糖药与二甲双胍治疗II型非胰岛素依赖型糖尿病
Sem Hop. 1983 Dec 29;59(49):3437-8.
10
A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes.SLC2A2 葡萄糖转运基因的变异可改变近期诊断的 2 型糖尿病患者接受二甲双胍治疗的血糖反应。
Diabetologia. 2019 Feb;62(2):286-291. doi: 10.1007/s00125-018-4759-z. Epub 2018 Nov 9.
本文引用的文献
1
A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.特立尼达 2 型糖尿病患者的多态性和二甲双胍反应研究方案。
Ethn Dis. 2020 Apr 2;30(Suppl 1):211-216. doi: 10.18865/ed.30.S1.211. eCollection 2020.
2
Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients.新诊断2型糖尿病患者初始抗糖尿病单药治疗的持久性及后续治疗调整模式
Ther Clin Risk Manag. 2018 Sep 3;14:1563-1571. doi: 10.2147/TCRM.S169964. eCollection 2018.
3
rs2075604 Polymorphism Is Associated with Metformin Efficacy in Chinese Type 2 Diabetes Mellitus.rs2075604基因多态性与中国2型糖尿病患者二甲双胍疗效相关。
Int J Endocrinol. 2017;2017:3402808. doi: 10.1155/2017/3402808. Epub 2017 Jul 9.
4
The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.SLC22A1基因rs594709位点和SLC47A1基因rs2289669位点多态性对中国2型糖尿病患者二甲双胍治疗疗效的影响
Int J Endocrinol. 2016;2016:4350712. doi: 10.1155/2016/4350712. Epub 2016 Feb 10.
5
Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review.二甲双胍和磺脲类衍生物初始使用者的反应预测因素：一项系统评价。
Diabet Med. 2015 Jul;32(7):853-64. doi: 10.1111/dme.12688. Epub 2015 Feb 9.
6
Quantifying the effect of metformin treatment and dose on glycemic control.量化二甲双胍治疗和剂量对血糖控制的影响。
Diabetes Care. 2012 Feb;35(2):446-54. doi: 10.2337/dc11-1465.
7
Multiple testing corrections for imputed SNPs.多重检验校正用于推断的 SNPs。
Genet Epidemiol. 2011 Apr;35(3):154-8. doi: 10.1002/gepi.20563. Epub 2011 Jan 19.
Zotero 插件